Minalrestat
Alternative Names: ARI 509; WAY 121509Latest Information Update: 02 Aug 2002
At a glance
- Originator Wyeth
- Class Antihyperglycaemics; Pyrrolidines; Small molecules; Tetrahydroisoquinolines
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic retinopathy